Product Information
PREZCOBIX 800 MG-150 MG TABLET is a brand product labeled by Janssen Products LP, priced at $79.9938 per EA under NDC 59676057530. Its NADAC has been published 590 times since Jun 17, 2015.
FDA first approved this application on Jan 29, 2015.
Strength
150; 800 mg/1; mg/1
Manufacturer
Janssen Products LPNDC
59676057530
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
COBICISTAT; DARUNAVIR ETHANOLATEApproval Type
New Drug (NDA)
FDA Application
NDA205395FDA Approved
1/29/2015
On Market Since
1/31/2015
Pharmacological Classes
Price Statistics
The NADAC for PREZCOBIX 800 MG-150 MG TABLET has been published 590 times since Jun 17, 2015, and over the history we have for it it has risen 73.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $79.9938 per EA |
|---|---|
| All-time high | $80.0004 (May 13, 2026) |
| All-time low | $46.0875 (Jun 17, 2015) |
| 52-week high | $80.0004 |
| 52-week low | $79.8731 |
| Median price | $68.0185 |
| Average price | $66.4469 |
| Largest weekly change | +7.9% (Jan 10, 2018) |
| Weeks tracked | 590 |
| Tracking since | Jun 17, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DARUNAVIR ETHANOLATE and COBICISTAT market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Janssen Products LP manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DARUNAVIR ETHANOLATE and COBICISTAT market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cytochrome P450 3A Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PREZCOBIX 800 MG-150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PREZCOBIX 800 MG-150 MG TABLET, manufactured by Janssen Products LP, is $79.9938 per EA (NDC 59676057530), effective Sep 30, 2026.
How has the price of PREZCOBIX 800 MG-150 MG TABLET changed over time?
Over the history we have for it, the NADAC for PREZCOBIX 800 MG-150 MG TABLET has risen 73.6%. It has been tracked across 590 weekly CMS publications since Jun 17, 2015.
What are the highest and lowest recorded NADAC prices for PREZCOBIX 800 MG-150 MG TABLET?
Since Jun 17, 2015, the NADAC for PREZCOBIX 800 MG-150 MG TABLET has ranged from a low of $46.0875 (Jun 17, 2015) to a high of $80.0004 (May 13, 2026), with a median of $68.0185 per EA.
Are there cheaper alternatives to PREZCOBIX 800 MG-150 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of PREZCOBIX 800 MG-150 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PREZCOBIX 800 MG-150 MG TABLET?
PREZCOBIX 800 MG-150 MG TABLET (NDC 59676057530) is labeled by Janssen Products LP, and CMS classifies it as a brand product.